Publication | Open Access
Accumulation of Transactive Response DNA Binding Protein 43 in Mild Cognitive Impairment and Alzheimer Disease
97
Citations
53
References
2011
Year
Molecular BiologyNeurochemical BiomarkersSynaptic SignalingSocial SciencesAlzheimer's DiseaseNeurobiology Of DiseaseSynaptic NeuroscienceExperimental NeuropathologyDegenerative PathologyProtein MisfoldingNeurologyBrain PathologyNeuropathologyNeurogeneticsMolecular NeuroscienceBiochemistryAlzheimer DiseaseNeurodegenerationMild Cognitive ImpairmentProtective MechanismsNeurodegenerative DiseasesAmyotrophic Lateral SclerosisCellular NeuroscienceDementiaNeuroscienceDetergent-insoluble Tdp-43Medicine
Transactive response DNA binding protein 43 (TDP-43) plays a central role in the neuropathology of frontotemporal lobar degeneration and amyotrophic lateral sclerosis, but the relationship between TDP-43 abnormalities and Alzheimer disease (AD) remains unclear. To determine whether TDP-43 can serve as a neuropathologic marker of AD, we performed biochemical characterization and quantification of TDP-43 in homogenates from parietal neocortex of subjects with aclinical diagnosis of no cognitive impairment (NCI, n = 12), mild cognitive impairment (MCI, n = 12), or AD (n = 12). Immunoblots revealed increased detergent-insoluble TDP-43 in the cortex of 0, 3, and 6 of the 12 individuals with NCI, MCI, or AD, respectively. Detergent-insoluble TDP-43 was positively correlated with the accumulation of soluble Aβ42, amyloid plaques, and paired helical filamenttau. In contrast, phospho-TDP-43 was decreased in the cytosolic fraction and detergent-soluble membrane/nuclear fraction from AD patients and correlated with antemortem cognitive function.Immunofluorescence analysis confirmed that the frequencies of individuals with TDP-43 or phospho-TDP-43 cytoplasmic inclusions were higher in AD than in NCI, with MCI at an intermediate level. These data indicate that abnormalities of TDP-43 occur in an important subset of MCI and AD patients and that they correlate with the clinical and neuropathologic features of AD.
| Year | Citations | |
|---|---|---|
Page 1
Page 1